David Kunke

  • Research scientist PhD
Mammalian group

Publications 2018

Pisal RV, Suchanek J, Siller R, Soukup T, Hrebikova H, Bezrouk A, Kunke D, Micuda S, Filip S, Sullivan G, Mokry J (2018)
Directed reprogramming of comprehensively characterized dental pulp stem cells extracted from natal tooth
Sci Rep, 8 (1), 6168
DOI 10.1038/s41598-018-24421-z, PubMed 29670257

Publications 2016

Pisal RV, Hrebíková H, Chvátalová J, Kunke D, Filip S, Mokrý J (2016)
Detection of Mycoplasma Contamination Directly from Culture Supernatant Using Polymerase Chain Reaction
Folia Biol (Praha), 62 (5), 203-206
PubMed 27978415

Publications 2013

Rolseth V, Krokeide SZ, Kunke D, Neurauter CG, Suganthan R, Sejersted Y, Hildrestrand GA, Bjørås M, Luna L (2013)
Loss of Neil3, the major DNA glycosylase activity for removal of hydantoins in single stranded DNA, reduces cellular proliferation and sensitizes cells to genotoxic stress
Biochim Biophys Acta, 1833 (5), 1157-64
DOI 10.1016/j.bbamcr.2012.12.024, PubMed 23305905

Publications 2012

Hviid CV, Erdem JS, Kunke D, Ahmed SM, Kjeldsen SF, Wang YY, Attramadal H, Aasen AO (2012)
The matri-cellular proteins 'cysteine-rich, angiogenic-inducer, 61' and 'connective tissue growth factor' are regulated in experimentally-induced sepsis with multiple organ dysfunction
Innate Immun, 18 (5), 717-26
DOI 10.1177/1753425912436764, PubMed 22334618

Publications 2011

Sejersted Y, Hildrestrand GA, Kunke D, Rolseth V, Krokeide SZ, Neurauter CG, Suganthan R, Atneosen-Åsegg M, Fleming AM, Saugstad OD, Burrows CJ, Luna L, Bjørås M (2011)
Endonuclease VIII-like 3 (Neil3) DNA glycosylase promotes neurogenesis induced by hypoxia-ischemia
Proc Natl Acad Sci U S A, 108 (46), 18802-7
DOI 10.1073/pnas.1106880108, PubMed 22065741

Wang W, Esbensen Y, Kunke D, Suganthan R, Rachek L, Bjørås M, Eide L (2011)
Mitochondrial DNA damage level determines neural stem cell differentiation fate
J Neurosci, 31 (26), 9746-51
DOI 10.1523/JNEUROSCI.0852-11.2011, PubMed 21715639

Publications 2009

Kunke D, Bryja V, Mygland L, Arenas E, Krauss S (2009)
Inhibition of canonical Wnt signaling promotes gliogenesis in P0-NSCs
Biochem Biophys Res Commun, 386 (4), 628-33
DOI 10.1016/j.bbrc.2009.06.084, PubMed 19545542

Publications 2007

Hildrestrand GA, Diep DB, Kunke D, Bolstad N, Bjørås M, Krauss S, Luna L (2007)
The capacity to remove 8-oxoG is enhanced in newborn neural stem/progenitor cells and decreases in juvenile mice and upon cell differentiation
DNA Repair (Amst), 6 (6), 723-32
DOI 10.1016/j.dnarep.2006.12.008, PubMed 17236821

Publications 2005

Lorico A, Bratbak D, Meyer J, Kunke D, Krauss S, Plott WE, Solodushko V, Baum C, Fodstad O, Rappa G (2005)
Gamma-glutamylcysteine synthetase and L-buthionine-(S,R)-sulfoximine: a new selection strategy for gene-transduced neural and hematopoietic stem/progenitor cells
Hum Gene Ther, 16 (6), 711-24
DOI 10.1089/hum.2005.16.711, PubMed 15960602

Publications 2004

Rappa G, Kunke D, Holter J, Diep DB, Meyer J, Baum C, Fodstad O, Krauss S, Lorico A (2004)
Efficient expansion and gene transduction of mouse neural stem/progenitor cells on recombinant fibronectin
Neuroscience, 124 (4), 823-30
DOI 10.1016/j.neuroscience.2003.11.030, PubMed 15026123

Publications 2003

Janousková O, Síma P, Kunke D (2003)
Combined suicide gene and immunostimulatory gene therapy using AAV-mediated gene transfer to HPV-16 transformed mouse cell: decrease of oncogenicity and induction of protection
Int J Oncol, 22 (3), 569-77
PubMed 12579310

Jinoch P, Zak R, Janousková O, Kunke D, Rittich S, Duskova M, Sobotkova E, Marinov I, Andelova M, Smahel M, Vonka V (2003)
Immunization with live HPV-16-transformed mouse cells expressing the herpes simplex thymidine kinase and either GM-CSF or IL-2
Int J Oncol, 23 (3), 775-83
PubMed 12888917

Publications 2000

Kunke D, Grimm D, Denger S, Kreuzer J, Delius H, Komitowski D, Kleinschmidt JA (2000)
Preclinical study on gene therapy of cervical carcinoma using adeno-associated virus vectors
Cancer Gene Ther, 7 (5), 766-77
DOI 10.1038/sj.cgt.7700178, PubMed 10830724

Publications 1996

Nemecková S, Sroller V, Kunke D, Krystofová J, Kutinová L (1996)
Hepatitis B virus core-preS2 particles expressed by recombinant vaccinia virus
Acta Virol, 40 (5-6), 273-9
PubMed 9171455

Publications 1995

Kutinová L, Ludvíková V, Simonová V, Otavová M, Krystofová J, Hainz P, Press M, Kunke D, Vonka V (1995)
Search for optimal parent for recombinant vaccinia virus vaccines. Study of three vaccinia virus vaccinal strains and several virus lines derived from them
Vaccine, 13 (5), 487-93
DOI 10.1016/0264-410x(94)00019-j, PubMed 7639016

Publications 1994

Kutinová L, Nĕmecková S, Hamsíková E, Závadová H, Ludvíková V, Broucek J, Kunke D, König J, Zakharova LG, Pashvykina GV (1994)
Hepatitis B virus proteins expressed by recombinant vaccinia viruses: influence of preS2 sequence on expression surface and nucleocapsid proteins in human diploid cells
Arch Virol, 134 (1-2), 1-15
DOI 10.1007/bf01379102, PubMed 8279947

Nĕmecková S, Kunke D, Press M, Nĕmecek V, Kutinová L (1994)
A carboxy-terminal portion of the preS1 domain of hepatitis B virus (HBV) occasioned retention in endoplasmic reticulum of HBV envelope proteins expressed by recombinant vaccinia viruses
Virology, 202 (2), 1024-7
DOI 10.1006/viro.1994.1431, PubMed 8030203

Nĕmecková S, Kutinová L, Kunke D, Schramlová J, Vonka V (1994)
[Construction of recombinant vaccinia viruses]
Cas Lek Cesk, 133 (24), 768-70
PubMed 7834680

Publications 1993

Kunke D, Broucek J, Kutinová L, Nĕmecková S, Ludvíková V, Strnad I, Kramosil J, Nemcová J, Schramlová J, Simonová V (1993)
Vaccinia virus recombinants co-expressing hepatitis B virus surface and core antigens
Virology, 195 (1), 132-9
DOI 10.1006/viro.1993.1353, PubMed 8317089

Publications 1992

Kutinová L, Nĕmecková S, Ludvíková V, Kunke D, Otavová M, Vonka V (1992)
[Problems associated with the development of vaccines based on recombinant vaccinia virus]
Cas Lek Cesk, 131 (24-25), 770-3
PubMed 1288884

Publications 1991

Ludvíková V, Kunke D, Hamsíková E, Kutinová L, Vonka V (1991)
Immunogenicity in mice of varicella-zoster virus glycoprotein I expressed by a vaccinia virus-varicella-zoster virus recombinant
J Gen Virol, 72 ( Pt 6), 1445-9
DOI 10.1099/0022-1317-72-6-1445, PubMed 1646285

Nĕmecková S, Kutinová L, Hamsíková E, Kunke D, Press M, Závadová H, Smrt J, Vonka V (1991)
Synthesis and immunogenicity of hepatitis B virus envelope antigen expressed by recombinant vaccinia virus. Finding of retention signal in the C-terminal portion of the preS1 domain of subtype adyw
Arch Virol, 121 (1-4), 29-41
DOI 10.1007/bf01316742, PubMed 1759909

Page visits: 5726